PACB (Pacific Biosciences of California) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PACB Pacific Biosciences of California Inc PACB
53 GF Score
Price $1.50
GF Value $1.62
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Net Loan?

Net Loan only applies to banks and insurance companies.

PACB
53GF Score
Pacific Biosciences of California Inc PACB
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pacific Biosciences of California (PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be undervalued. The current stock price of $1.50 is trading 7.7% below its estimated GF Value™ of $1.62. GuruFocus considers Pacific Biosciences of California to be Fairly Valued.

Key valuation signals for PACB:

  • Net Loan:
  • GF Value™: $1.62 vs. price of $1.50 (7.7% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacific Biosciences of California Business Description

Other Exchanges P09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score

Get the complete analysis for PACB

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.50
Price
$1.62
GF Value